{"provider_url":"https://hatena.blog","provider_name":"Hatena Blog","height":"190","version":"1.0","width":"100%","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Funeyama.hatenadiary.jp%2Fentry%2F20080307%2Fp10\" title=\"\u30d8\u30d1\u30ea\u30f3\u306e\u6c5a\u67d3\u7269\u8cea\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u6cd5 - \u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","author_name":"uneyama","categories":["FDA"],"title":"\u30d8\u30d1\u30ea\u30f3\u306e\u6c5a\u67d3\u7269\u8cea\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u6cd5","author_url":"https://blog.hatena.ne.jp/uneyama/","blog_url":"https://uneyama.hatenadiary.jp/","description":"FDA releases information on two tests that manufacturers and regulators can use to screen heparin for contaminants 3/6/2008 http://www.fda.gov/cder/drug/infopage/heparin/default.htm \u30ad\u30e3\u30d4\u30e9\u30ea\u30fc\u96fb\u6c17\u6cf3\u52d5\u3068\u30d7\u30ed\u30c8\u30f3NMR\u306e\u4e8c\u3064\u306e\u65b9\u6cd5\u304c\u63d0\u4f9b\u3055\u308c\u3066\u3044\u308b\u3002 \u6c5a\u67d3\u7269\u306f\u30d8\u30d1\u30ea\u30f3\u3068\u6975\u3081\u3066\u3088\u304f\u4f3c\u305f\u7269\u8cea\u3067\u3001\u666e\u901a\u306e\u8a66\u9a13\u3067\u306f\u691c\u51fa\u3067\u304d\u306a\u3044\u3002\u307e\u305f\u6c5a\u67d3\u306e\u7a0b\u5ea6\u306f5-20%\u3068\u304b\u306a\u308a\u306e\u91cf\u3067\u3042\u308b\u3002 \uff08\u30c9\u30a4\u30c4\u3067\u3082\u5225\u306e\u4f1a\u793e\u306e\u30d8\u30d1\u30ea\u30f3\u304c\u30ea\u30b3\u30fc\u30eb\u3055\u308c\u3066\u3044\u308b\uff09","blog_title":"\u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b","image_url":null,"published":"2008-03-07 00:00:10","type":"rich","url":"https://uneyama.hatenadiary.jp/entry/20080307/p10"}